The effect of kisspeptin on the maturation of human ovarian follicles in culture following vitrification-thawing processes.
BMP15
GDF 9
follicle maturation
human ovarian cryopreservation
kisspeptin
Journal
JBRA assisted reproduction
ISSN: 1518-0557
Titre abrégé: JBRA Assist Reprod
Pays: Brazil
ID NLM: 101684552
Informations de publication
Date de publication:
28 Sep 2023
28 Sep 2023
Historique:
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
aheadofprint
Résumé
Ovarian cryopreservation is one of the effective methods to preserve fertility for cancer patients. Still, this approach has some problems, namely ROS, resulting in adverse effects on oocytes and ovarian follicles. Kisspeptin as an antioxidant to control ovarian function, directly or indirectly. In this study, the effect of kisspeptin on follicle maturation was evaluated in culture following ovarian cryopreservation. Ovarian tissue samples of women between 20 and 35 years old (n=12) were laparoscopically collected. The samples were randomly divided into four groups: 1) control, 2) vitrification, 3) vitrified+1μM kisspeptin, and 4) vitrified+10μM kisspeptin. After vitrification and thawing processes, the tissues were cultured in DMEM medium for 7 days. H&E staining for histological evaluation, Real-Time PCR for GDF9 and BMP15 gene expression, and immunohistochemical staining for GDF9 and BMP15 protein expression were performed. In the vitrification group, ovarian tissue morphology was incoherent, and more primordial follicles than other follicle types were found. The expression of GDF9 and BMP15 genes and proteins were significantly decreased in this group compared with other groups (p<0.05). In the vitrification groups with kisspeptin (1 and 10 μM), the number of primary and secondary follicles was more than in the vitrification group. Besides, the expression of these genes and proteins was dramatically elevated in the vitrification groups with kisspeptin compared to the vitrification group alone (p<0.05). It seems that kisspeptin is an effective substance to improve the quality of the human ovarian cryopreservation medium by improving follicle maturation.
Identifiants
pubmed: 37768820
doi: 10.5935/1518-0557.20230045
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Reprod Domest Anim. 2009 Aug;44(4):653-8
pubmed: 19032440
Reprod Biol Endocrinol. 2019 Aug 9;17(1):65
pubmed: 31399145
Zygote. 2022 Jun;30(3):289-297
pubmed: 34676815
Mol Hum Reprod. 2009 Mar;15(3):155-64
pubmed: 19155222
Cryobiology. 2007 Feb;54(1):55-62
pubmed: 17196581
Sci Rep. 2014 Sep 18;4:6412
pubmed: 25231187
Gynecol Endocrinol. 2010 Aug;26(8):563-7
pubmed: 20230330
Toxicol Mech Methods. 2018 Nov;28(9):653-659
pubmed: 29968488
Sci Rep. 2017 Aug 17;7(1):8538
pubmed: 28819292
Reprod Med Biol. 2017 Sep 16;16(4):380-385
pubmed: 29259492
Domest Anim Endocrinol. 2016 Jul;56:36-47
pubmed: 27088601
J Reprod Infertil. 2017 Jan-Mar;18(1):162-171
pubmed: 28377895
Biol Reprod. 2016 Jun;94(6):137
pubmed: 26911431
Int J Mol Sci. 2021 Nov 19;22(22):
pubmed: 34830363
Exp Biol Med (Maywood). 2019 Apr;244(5):352-361
pubmed: 30781997
Sci Rep. 2017 Apr 18;7:45125
pubmed: 28417958
J Assist Reprod Genet. 2014 Apr;31(4):411-20
pubmed: 24477781
Taiwan J Obstet Gynecol. 2017 Aug;56(4):456-462
pubmed: 28805600
Best Pract Res Clin Obstet Gynaecol. 2012 Jun;26(3):379-90
pubmed: 22281514
Hum Reprod Update. 2010 Nov-Dec;16(6):617-30
pubmed: 20462941
J Biol Chem. 2001 Sep 14;276(37):34631-6
pubmed: 11457843
Endocrinology. 2006 Mar;147(3):1224-36
pubmed: 16339198
J Assist Reprod Genet. 2020 Sep;37(9):2119-2136
pubmed: 32651677
Int J Mol Sci. 2020 Feb 08;21(3):
pubmed: 32046301
Reprod Biomed Online. 2010 Jan;20(1):26-34
pubmed: 20158984
Mol Hum Reprod. 2017 May 1;23(5):282-291
pubmed: 28333275
Obes Rev. 2001 Nov;2(4):231-8
pubmed: 12119994
Front Med. 2021 Feb;15(1):144-154
pubmed: 32876878
Reprod Domest Anim. 2012 Jun;47(3):385-91
pubmed: 21950518
Best Pract Res Clin Obstet Gynaecol. 2021 Jan;70:63-80
pubmed: 32800711
Front Endocrinol (Lausanne). 2018 Jan 04;8:365
pubmed: 29354093
Transfus Med Hemother. 2019 Jun;46(3):173-181
pubmed: 31244585
Mol Reprod Dev. 2019 Nov;86(11):1603-1614
pubmed: 31408251
N Engl J Med. 2017 Oct 26;377(17):1657-1665
pubmed: 29069558
Theriogenology. 2016 Jan 15;85(2):315-22
pubmed: 26474685
Biopreserv Biobank. 2018 Aug;16(4):258-269
pubmed: 29957024
Reprod Fertil Dev. 2012;24(5):656-68
pubmed: 22697116
Fertil Steril. 2002 Sep;78(3):644-5
pubmed: 12215351
Gynecol Obstet Invest. 2013;75(3):157-62
pubmed: 23391858
Theriogenology. 2018 Jul 1;114:244-251
pubmed: 29660627
Fertil Steril. 2011 Jun;95(7):2274-8
pubmed: 21496799
Lancet Oncol. 2014 Sep;15(10):1129-36
pubmed: 25130994
Biol Reprod. 2003 Mar;68(3):881-7
pubmed: 12604638